NovaBay Pharmaceuticals, Inc. to Present at 2012 Southern California Investor Conference

EMERYVILLE, Calif., Aug. 20, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide® compounds for the local non-systemic treatment and prevention of infections, today announced that Dr. Ron Najafi, Chief Executive Officer, will present at the 2012 Southern California Investor Conference, held August 30, 2012, in Newport Beach, California.